Cypress Capital Group Quest Diagnostics Inc Transaction History

Cypress Capital Group

  • $827 Million
  • Q2 2024

A detailed history of Cypress Capital Group transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Cypress Capital Group holds 3,834 shares of DGX stock, worth $525,603. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,834
Previous 2,186 75.39%
Holding current value
$525,603
Previous $290,000 80.69%
% of portfolio
0.06%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
BUY
$125.91 - $144.34 $207,499 - $237,872
1,648 Added 75.39%
3,834 $524,000
Q1 2024

May 08, 2024
SELL
$123.78 - $142.11 $199,409 - $228,939
-1,611 Reduced 42.43%
2,186 $290,000
Q3 2023

Nov 02, 2023
SELL
$121.86 - $144.92 $163,292 - $194,192
-1,340 Reduced 26.09%
3,797 $462,000
Q2 2023

Jul 26, 2023
SELL
$130.56 - $146.84 $130 - $146
-1 Reduced 0.02%
5,137 $722,000
Q1 2023

May 04, 2023
SELL
$131.53 - $155.76 $485,082 - $574,442
-3,688 Reduced 41.79%
5,138 $726,000
Q4 2022

Feb 14, 2023
BUY
$123.31 - $157.26 $33,663 - $42,931
273 Added 3.19%
8,826 $1.38 Million
Q3 2022

Nov 04, 2022
BUY
$121.77 - $141.1 $487 - $564
4 Added 0.05%
8,553 $1.05 Million
Q2 2022

Jul 26, 2022
SELL
$127.07 - $145.39 $6,607 - $7,560
-52 Reduced 0.6%
8,549 $1.14 Million
Q1 2022

May 16, 2022
BUY
$129.09 - $164.35 $14,070 - $17,914
109 Added 1.28%
8,601 $1.18 Million
Q4 2021

Feb 15, 2022
SELL
$140.36 - $173.01 $10,948 - $13,494
-78 Reduced 0.91%
8,492 $1.47 Million
Q3 2021

Oct 12, 2021
BUY
$132.95 - $158.0 $631,512 - $750,500
4,750 Added 124.35%
8,570 $1.25 Million
Q2 2021

Jul 13, 2021
SELL
$126.66 - $141.48 $3,673 - $4,102
-29 Reduced 0.75%
3,820 $504,000
Q1 2021

Apr 14, 2021
SELL
$114.63 - $133.34 $295,860 - $344,150
-2,581 Reduced 40.14%
3,849 $494,000
Q4 2020

Jan 12, 2021
SELL
$112.7 - $128.05 $294,259 - $334,338
-2,611 Reduced 28.88%
6,430 $767,000
Q3 2020

Oct 08, 2020
BUY
$107.05 - $130.01 $130,172 - $158,092
1,216 Added 15.54%
9,041 $1.04 Million
Q2 2020

Jul 10, 2020
BUY
$73.34 - $122.61 $264,390 - $442,009
3,605 Added 85.43%
7,825 $892,000
Q1 2020

Apr 08, 2020
BUY
$75.14 - $115.68 $63,869 - $98,328
850 Added 25.22%
4,220 $339,000
Q3 2019

Oct 10, 2019
BUY
$97.85 - $107.42 $8,806 - $9,667
90 Added 2.74%
3,370 $361,000
Q2 2019

Aug 15, 2019
SELL
$85.18 - $101.94 $18,313 - $21,917
-215 Reduced 6.15%
3,280 $334,000
Q1 2019

May 14, 2019
BUY
$80.68 - $89.92 $281,976 - $314,270
3,495 New
3,495 $314,000
Q2 2018

Aug 15, 2018
SELL
$97.35 - $113.14 $199,567 - $231,937
-2,050 Closed
0 $0
Q1 2018

May 21, 2018
BUY
$96.42 - $107.88 $197,661 - $221,154
2,050 New
2,050 $205,000

Others Institutions Holding DGX

# of Institutions
909
Shares Held
96.1M
Call Options Held
587K
Put Options Held
235K
View Full List

About QUEST DIAGNOSTICS INC

DGX Quotes by TradingView
  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Cypress Capital Group Portfolio

Follow Cypress Capital Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email